3301 - 3350 of 8436 Results
Title
Year
-
OPENTitle: Correction: Data Sharing Goals for Nonprofit Funders of Clinical TrialsJournal Name: Journal of Participatory MedicinePublisher: JMIR Publications Inc.Vol: 13Issue #: 2Start Page: e31371End Page: e31371Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2196/31371Best OA location URL: https://jopm.jmir.org/2021/2/e31371/PDFCitation Count: 0
- Moving towards Integrated and Personalized Care in Parkinson’s Disease: A Framework Proposal for Training Parkinson Nurses2021RESTRICTEDTitle: Moving towards Integrated and Personalized Care in Parkinson’s Disease: A Framework Proposal for Training Parkinson NursesJournal Name: Journal of Personalized MedicinePublisher: MDPI AGVol: 11Issue #: 7Start Page: 623End Page: 623Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/jpm11070623Best OA location URL: https://www.mdpi.com/2075-4426/11/7/623/pdf?version=1625207859Citation Count: 20
-
RESTRICTEDTitle: On demand therapy for Parkinson’s disease patients: Opportunities and choicesJournal Name: Postgraduate MedicinePublisher: Informa UK LimitedVol: 133Issue #: 7Start Page: 721End Page: 727Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/00325481.2021.1936087Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/00325481.2021.1936087?needAccess=trueCitation Count: 16
- Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept Trial2021OPENTitle: Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2408End Page: 2412Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28702Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596433Citation Count: 14
- A new alpha-synuclein missense variant (Thr72Met) in two Turkish families with Parkinson's disease2021OPENTitle: A new alpha-synuclein missense variant (Thr72Met) in two Turkish families with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 63End Page: 72Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.06.023Best OA location URL: http://www.prd-journal.com/article/S1353802021002431/pdfCitation Count: 22
-
OPENTitle: Proceedings of Reanimation 2021, the French Intensive Care Society International CongressJournal Name: Annals of Intensive CarePublisher: Springer Science and Business Media LLCVol: 11Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13613-021-00862-0Best OA location URL: https://annalsofintensivecare.springeropen.com/track/pdf/10.1186/s13613-021-00862-0Citation Count: 6
- Protocol for the DeFOG trial: A randomized controlled trial on the effects of smartphone-based, on-demand cueing for freezing of gait in Parkinson's disease2021OPENTitle: Protocol for the DeFOG trial: A randomized controlled trial on the effects of smartphone-based, on-demand cueing for freezing of gait in Parkinson's diseaseJournal Name: Contemporary Clinical Trials CommunicationsPublisher: Elsevier BVVol: 24Issue #:Start Page: 100817End Page: 100817Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.conctc.2021.100817Best OA location URL: https://doi.org/10.1016/j.conctc.2021.100817Citation Count: 18
- Temporal Ordering of Inflammatory Analytes sTNFR2 and sTREM2 in Relation to Alzheimer's Disease Biomarkers and Clinical Outcomes2021OPENTitle: Temporal Ordering of Inflammatory Analytes sTNFR2 and sTREM2 in Relation to Alzheimer's Disease Biomarkers and Clinical OutcomesJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.676744Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.676744/pdfCitation Count: 12
- CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLB2021OPENTitle: CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLBJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2595End Page: 2604Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28704Best OA location URL: https://discovery.ucl.ac.uk/10131553/1/mds.28704.pdfCitation Count: 19
- Directed Brain Connectivity Identifies Widespread Functional Network Abnormalities in Parkinson’s Disease2021OPENTitle: Directed Brain Connectivity Identifies Widespread Functional Network Abnormalities in Parkinson’s DiseaseJournal Name: Cerebral CortexPublisher: Oxford University Press (OUP)Vol: 32Issue #: 3Start Page: 593End Page: 607Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/cercor/bhab237Best OA location URL: https://academic.oup.com/cercor/article-pdf/32/3/593/42259699/bhab237.pdfCitation Count: 13
- High cerebrospinal amyloid-β 42 is associated with normal cognition in individuals with brain amyloidosis2021OPENTitle: High cerebrospinal amyloid-β 42 is associated with normal cognition in individuals with brain amyloidosisJournal Name: eClinicalMedicinePublisher: Elsevier BVVol: 38Issue #:Start Page: 100988End Page: 100988Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.eclinm.2021.100988Best OA location URL: https://doi.org/10.1016/j.eclinm.2021.100988Citation Count: 104
-
OPENTitle: Home Health Management of Parkinson Disease Deep Brain StimulationJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 8Start Page: 972End Page: 972Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.1910Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240011Citation Count: 16
- Too much for your own good: Excessive dopamine damages neurons and contributes to Parkinson's disease2021RESTRICTEDTitle: Too much for your own good: Excessive dopamine damages neurons and contributes to Parkinson's diseaseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 158Issue #: 4Start Page: 833End Page: 836Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/jnc.15442Citation Count: 9
-
OPENTitle: White Matter Hyperintensities Are Associated With Severity of Essential Tremor in the ElderlyJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.694286Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.694286/pdfCitation Count: 10
-
RESTRICTEDTitle: Disrupted rich-club organization of brain structural networks in Parkinson’s diseaseJournal Name: Brain Structure and FunctionPublisher: Springer Science and Business Media LLCVol: 226Issue #: 7Start Page: 2205End Page: 2217Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00429-021-02319-3Citation Count: 18
- Parkinson's disease-related pattern (PDRP) identified using resting-state functional MRI: Validation study2021OPENTitle: Parkinson's disease-related pattern (PDRP) identified using resting-state functional MRI: Validation studyJournal Name: Neuroimage: ReportsPublisher: Elsevier BVVol: 1Issue #: 3Start Page: 100026End Page: 100026Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ynirp.2021.100026Best OA location URL: https://doi.org/10.1016/j.ynirp.2021.100026Citation Count: 17
-
OPENTitle: Preoperative Evaluation of Parkinson’s DiseaseJournal Name: CureusPublisher: Springer Science and Business Media LLCVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7759/cureus.15933Best OA location URL: https://www.cureus.com/articles/62358-preoperative-evaluation-of-parkinsons-disease.pdfCitation Count: 1
-
OPENTitle: An image-based flow cytometric approach to the assessment of the nucleus-to-cytoplasm ratioJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 6Start Page: e0253439End Page: e0253439Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1371/journal.pone.0253439Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0253439&type=printableCitation Count: 3
-
RESTRICTEDTitle: Coincident parkinsonism and myasthenia gravis: A case seriesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 4End Page: 5Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.06.016Citation Count: 6
- Low continuation of antipsychotic therapy in Parkinson disease – intolerance, ineffectiveness, or inertia?2021OPENTitle: Low continuation of antipsychotic therapy in Parkinson disease – intolerance, ineffectiveness, or inertia?Journal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-021-02265-xBest OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-021-02265-xCitation Count: 15
- Caregiver-Reported Burden in RE-KINECT: Data From a Prospective Real-World Tardive Dyskinesia Screening Study2021OPENTitle: Caregiver-Reported Burden in RE-KINECT: Data From a Prospective Real-World Tardive Dyskinesia Screening StudyJournal Name: Journal of the American Psychiatric Nurses AssociationPublisher: SAGE PublicationsVol: 29Issue #: 5Start Page: 389End Page: 399Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/10783903211023565Best OA location URL: https://doi.org/10.1177/10783903211023565Citation Count: 8
-
OPENTitle: Correction: VPS13D bridges the ER to mitochondria and peroxisomes via MiroJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 220Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1083/jcb.20201000405052021cBest OA location URL: https://rupress.org/jcb/article-pdf/220/8/e20201000405052021c/1418389/jcb_20201000405052021c.pdfCitation Count: 9
-
RESTRICTEDTitle: Genetic Defects and Pro-inflammatory Cytokines in Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.636139Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.636139/pdfCitation Count: 29
- Slow Motion Analysis of Repetitive Tapping (SMART) Test: Measuring Bradykinesia in Recently Diagnosed Parkinson’s Disease and Idiopathic Anosmia2021OPENTitle: Slow Motion Analysis of Repetitive Tapping (SMART) Test: Measuring Bradykinesia in Recently Diagnosed Parkinson’s Disease and Idiopathic AnosmiaJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 4Start Page: 1901End Page: 1915Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-212683Best OA location URL: https://www.medrxiv.org/content/medrxiv/early/2021/03/26/2021.03.24.21254234.full.pdfCitation Count: 9
- The development of inhibitors of leucine‐rich repeat kinase 2 (LRRK2) as a therapeutic strategy for Parkinson's disease: the current state of play2021RESTRICTEDTitle: The development of inhibitors of leucine‐rich repeat kinase 2 (LRRK2) as a therapeutic strategy for Parkinson's disease: the current state of playJournal Name: British Journal of PharmacologyPublisher: WileyVol: 179Issue #: 8Start Page: 1478End Page: 1495Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1111/bph.15575Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.15575Citation Count: 36
- Impact of Chorea on Self-care Activity, Employment, and Health-care Resource Use in Patients with Huntington’s Disease2021OPENTitle: Impact of Chorea on Self-care Activity, Employment, and Health-care Resource Use in Patients with Huntington’s DiseaseJournal Name: Journal of Health Economics and Outcomes ResearchPublisher: The Journal of Health Economics and Outcomes ResearchVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.36469/001c.24620Best OA location URL: https://jheor.org/article/24620.pdfCitation Count: 6
- Preformed fibrils generated from mouse alpha-synuclein produce more inclusion pathology in rats than fibrils generated from rat alpha-synuclein2021OPENTitle: Preformed fibrils generated from mouse alpha-synuclein produce more inclusion pathology in rats than fibrils generated from rat alpha-synucleinJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 41End Page: 47Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.06.010Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429263Citation Count: 11
-
OPENTitle: Poly (ADP-ribose) Interacts With Phosphorylated α-Synuclein in Post Mortem PD SamplesJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.704041Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.704041/pdfCitation Count: 19
- Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pT73 Rab102021OPENTitle: Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pT73 Rab10Journal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-91943-4Best OA location URL: https://www.nature.com/articles/s41598-021-91943-4.pdfCitation Count: 48
- Clinical Features of Patients With Progressive Supranuclear Palsy in an US Insurance Claims Database2021OPENTitle: Clinical Features of Patients With Progressive Supranuclear Palsy in an US Insurance Claims DatabaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.571800Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.571800/pdfCitation Count: 23
- Evaluation of Individualized Multi‐Disciplinary Inpatient Treatment for Functional Movement Disorders2021OPENTitle: Evaluation of Individualized Multi‐Disciplinary Inpatient Treatment for Functional Movement DisordersJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 6Start Page: 911End Page: 918Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13268Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13268Citation Count: 17
- Impact of Chorea on Self-care Activity, Employment, and Health-care Resource Use in Patients with Huntington’s Disease2021OPENTitle: Impact of Chorea on Self-care Activity, Employment, and Health-care Resource Use in Patients with Huntington’s DiseaseJournal Name: Journal of Health Economics and Outcomes ResearchPublisher: The Journal of Health Economics and Outcomes ResearchVol: 8Issue #: 1Start Page: 99End Page: 105Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.36469/jheor.2021.24620Best OA location URL: https://jheor.org/article/24620.pdfCitation Count: 1
- Ondine's Curse in Frontotemporal Dementia with Parkinsonism Linked to Chromosome 17 Caused by MAPT Variants2021OPENTitle: Ondine's Curse in Frontotemporal Dementia with Parkinsonism Linked to Chromosome 17 Caused by MAPT VariantsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 6Start Page: 954End Page: 958Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13265Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13265Citation Count: 1
-
OPENTitle: Thyrotoxicosis Resulting in Unilateral Upper Limb Chorea and BallismusJournal Name: Canadian Journal of Neurological Sciences / Journal Canadien des Sciences NeurologiquesPublisher: Cambridge University Press (CUP)Vol: 49Issue #: 3Start Page: 431End Page: 432Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/cjn.2021.136Citation Count: 3
-
OPENTitle: Analysis of PTRHD1 common and rare variants in European patients with Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 107Issue #:Start Page: 178End Page: 180Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.06.005Best OA location URL: http://manuscript.elsevier.com/S0197458021001986/pdf/S0197458021001986.pdfCitation Count: 2
- Correction to A Single Amino Acid Determines the Selectivity and Efficacy of Selective Negative Allosteric Modulators of CaV1.3 L-Type Calcium Channels2021RESTRICTEDTitle: Correction to A Single Amino Acid Determines the Selectivity and Efficacy of Selective Negative Allosteric Modulators of CaV1.3 L-Type Calcium ChannelsJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 16Issue #: 7Start Page: 1299End Page: 1300Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschembio.1c00368Citation Count: 2
-
OPENTitle: Freezing of gait and levodopaJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 7Start Page: 505End Page: 506Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00175-7Best OA location URL: http://www.thelancet.com/article/S1474442221001757/pdfCitation Count: 8
-
RESTRICTEDTitle: Frühzeichen der Parkinson-ErkrankungJournal Name: DGNeurologiePublisher: Springer Science and Business Media LLCVol: 4Issue #: 4Start Page: 295End Page: 303Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s42451-021-00352-4Citation Count: 0
-
OPENTitle: Prehospital scales in acute ischaemic stroke management – Authors' replyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 7Start Page: 504End Page: 505Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00169-1Best OA location URL: http://www.thelancet.com/article/S1474442221001691/pdfCitation Count: 1
- Protein phosphatase 2A holoenzymes regulate leucine-rich repeat kinase 2 phosphorylation and accumulation2021OPENTitle: Protein phosphatase 2A holoenzymes regulate leucine-rich repeat kinase 2 phosphorylation and accumulationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 157Issue #:Start Page: 105426End Page: 105426Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105426Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105426Citation Count: 10
- Rare CASP6N73T variant associated with hippocampal volume exhibits decreased proteolytic activity, synaptic transmission defect, and neurodegeneration2021OPENTitle: Rare CASP6N73T variant associated with hippocampal volume exhibits decreased proteolytic activity, synaptic transmission defect, and neurodegenerationJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-91367-0Best OA location URL: https://www.nature.com/articles/s41598-021-91367-0.pdfCitation Count: 12
- Synergistic effects of autophagy/mitophagy inhibitors and magnolol promote apoptosis and antitumor efficacy2021OPENTitle: Synergistic effects of autophagy/mitophagy inhibitors and magnolol promote apoptosis and antitumor efficacyJournal Name: Acta Pharmaceutica Sinica BPublisher: Elsevier BVVol: 11Issue #: 12Start Page: 3966End Page: 3982Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.apsb.2021.06.007Best OA location URL: https://doi.org/10.1016/j.apsb.2021.06.007Citation Count: 44
-
RESTRICTEDTitle: The Gastrointestinal Dysfunction Scale for Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2358End Page: 2366Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28675Citation Count: 14
- Validity and reliability of the suggested immobilization test for measurement of restless legs syndrome severity in adults with multiple sclerosis2021OPENTitle: Validity and reliability of the suggested immobilization test for measurement of restless legs syndrome severity in adults with multiple sclerosisJournal Name: Sleep MedicinePublisher: Elsevier BVVol: 84Issue #:Start Page: 343End Page: 351Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.sleep.2021.06.005Best OA location URL: http://manuscript.elsevier.com/S1389945721003361/pdf/S1389945721003361.pdfCitation Count: 6
- Comparison of Different Platform Immunoassays for the Measurement of Plasma Alpha-Synuclein in Parkinson’s Disease Patients2021OPENTitle: Comparison of Different Platform Immunoassays for the Measurement of Plasma Alpha-Synuclein in Parkinson’s Disease PatientsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 4Start Page: 1761End Page: 1772Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212694Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212694?id=journal-of-parkinsons-disease%2Fjpd212694Citation Count: 24
-
OPENTitle: In Silico Studies Comparing the Adjuvant Therapies Approved for Parkinson’s diseaseJournal Name: Journal of Drug Delivery and TherapeuticsPublisher: Society of Pharmaceutical TecnocratsVol: 11Issue #: 3-SStart Page: 104End Page: 110Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.22270/jddt.v11i3-s.4813Best OA location URL: http://jddtonline.info/index.php/jddt/article/download/4813/3895Citation Count: 1
- Multi‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer’s disease2021OPENTitle: Multi‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer’s diseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 7Start Page: 1456End Page: 1470Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51402Best OA location URL: https://hal.sorbonne-universite.fr/hal-03263514/file/acn3.51402.pdfCitation Count: 32
-
RESTRICTEDTitle: Novel Genes May Drive Progression in Parkinson's DiseaseJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 12Start Page: 25End Page: 26Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000756456.16968.c1Citation Count: 0
- Vagus Nerve and Stomach Synucleinopathy in Parkinson’s Disease, Incidental Lewy Body Disease, and Normal Elderly Subjects: Evidence Against the “Body-First” Hypothesis2021OPENTitle: Vagus Nerve and Stomach Synucleinopathy in Parkinson’s Disease, Incidental Lewy Body Disease, and Normal Elderly Subjects: Evidence Against the “Body-First” HypothesisJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 4Start Page: 1833End Page: 1843Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-212733Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082635Citation Count: 62
- Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease2021OPENTitle: Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2303End Page: 2313Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28682Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28682Citation Count: 47